A process for the conversion of the major antifungal antibiotic, acid s (ATCC No. 25532) isolated from the fermentation of Polyangium cellulosum var. fulvum into the minor antibiotic, acid F, from the same fermentation is described wherein acid s is methylated with diazomethane to provide acid s methyl ester which is then oxidized with silver carbonate on celite to obtain the corresponding keto ester s, which is subsequently reduced with sodium borohydride to give a mixture of acid s methyl ester and acid F methyl ester. These esters are readily separated by preparative thin layer chromatography and the acid F methyl ester is hydrolyzed with sodium hydroxide solution to provide acid F.
|
1. A process for preparing the substance acid F (V) having the following formula: ##STR6## which comprises the following steps: A. Reducing an alcoholic solution of keto ester s (III) wherein the keto ester s has the following formula: ##STR7## with an alkali metal borohydride to obtain a mixture of acid s methyl ester II and acid F methyl ester IV having the following formulas: ##STR8## B. Separating acid s methyl ester II and acid F methyl ester IV by preparative thin layer chromatography;
C. Hydrolyzing acid F methyl ester IV to obtain the desired acid F (V).
2. A process according to
3. A process according to
|
The present invention is concerned with a process for the conversion of the major antifungal antibiotic (acid S) isolated from the fermentation of Polyangium cellulosum var. fulvum into the minor antibiotic (acid F) from the same fermentation. Acid F is isolated either in small amounts or in many cases not at all from the fermentation medium. Thus, in order to have an adequate supply of acid F, it has been found necessary to design a process for the conversion of the readily available acid S into acid F.
Acid S and acid F are described in U.S. Pat. Nos. 3,651,216 and 3,804,948. As disclosed in these patents, both acid S and acid F are potent antifungal agents. In addition, U.S. Pat. No. 3,804,948 describes the chemical preparation of the methyl ester of acid S. Keto ester S, a derivative of acid S, disclosed in U.S. Pat. No. 3,932,620 is also used in the process of this invention.
The process of the invention is shown in Scheme A as follows: ##STR1## Acid S (I) is methylated with diazomethane to provide acid S methyl ester II, which is oxidized with silver carbonate on celite to obtain keto ester S (III). Attempts to oxidize acid S directly to keto S yields tars, but selective oxidation of acid S methyl ester to keto ester S, following the procedure described in U.S. Pat. No. 3,932,620 is successful.
Keto ester S(III), in an alcoholic solvent such as methanol, is reduced with an alkali metal borohydride, typically sodium borohydride, to provide a mixture of acid S methyl ester II and acid F methyl ester IV. The reduction step may be conducted under nitrogen. These esters are readily separated by preparative thin layer chromatography. A typical solvent system which may be used for this separation is ethyl acetate-cyclohexane in a ratio of 4:1. Variations of this solvent system, commonly used in thin layer chromatography separations are also suitable.
The acid F methyl ester IV thus obtained is hydrolyzed to obtain acid F (V). The hydrolysis is conducted in an alcoholic solvent, such as methanol, using alkali metal hydroxide, typically sodium hydroxide. The hydrolysis step may be conducted under nitrogen.
To confirm the structure of acid F (V), the diacetate VI of the semi-synthetic product was prepared. A sample of natural acid F (VII) obtained from the fermentation was also acetylated to obtain acid F diacetate VIII. The NMR spectra of the two diacetates VI and VIII were found to be identical in all respects, indicating that the semi-synthetic product VI is acid F diacetate. Thus, the semi-synthetic product V is identical to natural acid F (VII) isolated from the fermentation of Polyangium cellulosum var. fulvum. The infra-red spectra of semi-synthetic acid F (V) and natural acid F (VII) are also identical.
The following examples are provided to further illustrate the invention and are not be construed as limiting the scope of the invention.
IR γ max broad 3600-3200 and 2800-2500 (OH), 1720 cm-1 (CO)
______________________________________ |
Mass Spectrum |
______________________________________ |
Observed molecular ion 474.3010 |
Calculated for C28 H42 O5 |
474.2981 |
______________________________________ |
m/e (relative intensity) 474(14), 456(9), 445(29), 379(19), 361(8), 279(64), 245(19), 235(21), 195(75) and 193(100).
IR γ max broad 3500-3100 and 2800-2400(OH), 1745 (CO) and 1720 cm-1 (CO)
______________________________________ |
Mass Spectrum |
______________________________________ |
Observed molecular ion 558.3295 |
Calculated for C32 H46 O8 |
558.3271 |
______________________________________ |
m/e (relative intensity) 558(17), 529(50), 463(21), 343(10), 305(10), 259(7), 245(23), 195(23) and 193(100).
NMR (CDCl3) δ 0.89 (s, 3H, CH3), 1.05 (m, 6H, 2CH3), 1.59 (s, 3H, CH3), 1.64 (s, 3H, CH3), 1.98 (s, 3H, CH3 CO), 2.14 (s, 3H, CH3 CO), 2.44 (q, 1H, CH2 CO), 2.65 (q, 1H, CH2 CO), 3.07 (m, 1H, bisallyl), 3.86 (q, 1H, CH--O), 4.07-4.29 (m, 3H, 3CH--O), 4.67 (q, 1H, CH--OAc), 5.06 (q, 1H, vinyl), 5.25 (d, 1H, vinyl), 5.32-5.52 (m, 4H, 3 vinyl and 1 CH--OAc) and 5.57 (d, 1H, vinyl).
IR γ max broad 3500-3100 and 2800-2400(OH), 1745(CO) and 1720 cm-1 (CO).
______________________________________ |
Mass Spectrum |
______________________________________ |
Observed molecular ion 558.3249 |
Calculated for C32 H46 O8 |
558.3271 |
______________________________________ |
m/e (relative intensity) 558(26), 529(44), 463(30), 343(12), 305(14), 259(14), 245(21), 195(90) and 193(100)
NMR (CDCl3) δ 0.89 (s, 3H, CH3), 1.05 (m, 6H, 2CH3), 1.59 (s, 3H, CH3), 1.64 (s, 3H, CH3), 1.98 (s, 3H, CH3 CO), 2.14 (s, 3H, CH3 CO), 2.44 (q, 1H, CH2 CO), 2.65 (q, 1H, CH2 CO), 3.07 (m, 1H, bisallyl), 3.86 (q, 1H, CH--O), 4.07-4.29 (m, 3H, 3CH--O), 4.67 (q, 1H, CH--OAc), 5.06 (q, 1H, vinyl), 5.25 (d, 1H, vinyl), 5.32-5.52 (m, 4H, 3 vinyl and 1CH--OAc) and 5.57 (d, 1H, vinyl).
Connor, David T., VON Strandtmann, Maximilian
Patent | Priority | Assignee | Title |
Patent | Priority | Assignee | Title |
3651216, | |||
3804948, | |||
4001398, | Jun 24 1974 | Warner-Lambert Company | Octahydro and decahydro derivatives of acid S, an antibiotic produced by Polyangium cellulosum var. fulvum |
4009261, | Aug 07 1975 | Warner-Lambert Company | 7-Substituted triol derivatives of acid S, an antibiotic produced by polyangium cellulosum var. fulvum |
4016257, | Aug 07 1975 | Warner-Lambert Company | Amide derivatives of acids, an antibiotic produced by Polyangium cellulosum var. fulvum |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jul 14 1978 | Warner-Lambert Company | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Date | Maintenance Schedule |
Jul 15 1983 | 4 years fee payment window open |
Jan 15 1984 | 6 months grace period start (w surcharge) |
Jul 15 1984 | patent expiry (for year 4) |
Jul 15 1986 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jul 15 1987 | 8 years fee payment window open |
Jan 15 1988 | 6 months grace period start (w surcharge) |
Jul 15 1988 | patent expiry (for year 8) |
Jul 15 1990 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jul 15 1991 | 12 years fee payment window open |
Jan 15 1992 | 6 months grace period start (w surcharge) |
Jul 15 1992 | patent expiry (for year 12) |
Jul 15 1994 | 2 years to revive unintentionally abandoned end. (for year 12) |